Imagify™ (perflubutane polymer microspheres) injectable suspension for the assessment of coronary artery disease

References

• Kaul S. Myocardial contrast echocardiography in coronary artery disease: potential applications using venous injections of contrast. Am. J. Cardiol.75(11), 61D–68D (1995).
   PubMed Web of Science ®Google Scholar
• Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation97(5), 473–483 (1998).
   PubMed Web of Science ®Google Scholar
• Monaghan M. Myocardial perfusion imaging during stress using contrast echocardiography. In: Contrast Echocardiography in Clinical Practice. Zamarano JL, Garcia-Fernandez MA (Eds). Springer, Milan, Italy, 175–190 (2007).
   Google Scholar
• Moir S, Haluska BA, Jenkins C, Fathi R, Marwick TH. Incremental benefit of myocardial contrast to combined dipyridamole – exercise stress echocardiography for the assessment of coronary artery disease. Circulation110(9), 1108–1113 (2004).
   PubMed Web of Science ®Google Scholar
• Wei K, Crouse L, Weiss J et al. Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 multicenter Phase 2 trial results). Am. J. Cardiol.91(11), 1293–1298 (2003).
   PubMed Web of Science ®Google Scholar
• Senior R, Lepper W, Pasquet A et al. Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. Am. Heart J.147(6), 1100–1105 (2004).
   PubMed Web of Science ®Google Scholar
• Peltier M, Vancraeynest D, Pasquet A et al. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography. Comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J. Am. Coll. Cardiol.43(2), 257–264 (2004).
   PubMed Web of Science ®Google Scholar
• Jeetley P, Hickman M, Kamp O et al. Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J. Am. Coll. Cardiol.47(1), 141–145 (2006).
   PubMed Web of Science ®Google Scholar
• Dijkmans PA, Senior R, Becher H et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J. Am. Coll. Cardiol.48(11), 2168–2177 (2006).
   PubMed Web of Science ®Google Scholar
• Porter T, Kricsfeld D, Cheatham S, Li S. Effect of blood and microbubble oxygen and nitrogen content on perfluorocarbon-filled dextrose albumin microbubble size and efficacy: in vitro and in vivo studies. J. Am. Soc. Echocardiogr.11(5), 421–425 (1998).
   PubMed Web of Science ®Google Scholar
• Porter TR, Xie F, Li S, D’Sa A, Rafter P. Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging. J. Am. Soc. Echocardiogr.9(5), 599–605 (1996).
   PubMedGoogle Scholar
• Porter TR, Li S, Kricsfeld D, Armbruster RW. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging. J. Am. Coll. Cardiol.29(4), 791–799 (1997).
   PubMed Web of Science ®Google Scholar
• Porter TR, Li S, Jiang L, Grayburn P, Deligonul U. Real-time visualization of myocardial perfusion and wall thickening in human beings with intravenous ultrasonographic contrast and accelerated intermittent harmonic imaging. J. Am. Soc. Echocardiogr.12(4), 266–271 (1999).
   PubMed Web of Science ®Google Scholar
• Yao J, Takeuchi M, Teupe C et al. Evaluation of a new ultrasound contrast agent (AI-700) using two-dimensional and three-dimensional imaging during acute ischemia. J. Am. Soc. Echocardiogr.15(7), 686–694 (2002).
   PubMed Web of Science ®Google Scholar
• Picard M, Pandian N, Morcerf F et al. The effects of AI-700 echo-contrast perfusion and/or wall motion imaging on detection of perfusion in patients with coronary artery disease [Abstract]. J. Am. Soc. Echocardiogr.14, 460 (2001).
   Web of Science ®Google Scholar
• Shimoni S, Zoghbi WA, Xie F et al. Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography. J. Am. Coll. Cardiol.37(3), 741–747 (2001).
   PubMed Web of Science ®Google Scholar
• Church CC. The acoustical responses of AI-700 in vitro [Abstract]. J. Am. Soc. Echocardiogr.13, 457 (2000).
   Google Scholar
• Hamilos MI, Patrianakos AP. AI-700 (Acusphere). Curr. Opin. Investig. Drugs6(9), 956–961 (2005).
   PubMedGoogle Scholar
• Straub JA, Chickering DE, Church CC, Shah B, Hanlon T, Bernstein H. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J. Control. Release108(1), 21–32 (2005).
   PubMed Web of Science ®Google Scholar
• Acusphere Inc. Investigator’s brochure: investigational product AI-700. Edition 5.0 (2006).
   Google Scholar
• Straub JA, Chickering DE, Hartman TG, Gloff CA, Bernstein H. AI-700 pharmacokinetics, tissue distribution and exhaled elimination kinetics in rats. Int. J. Pharm.328(1), 35–41 (2007).
   PubMedGoogle Scholar
• Di Spirito M, Marier JF, Di Marco M, Ducharme MP, O’Dea CR, Walovitch RC. The pharmacokinetics of a perfluorocarbon gas – an echocardiographic contrast agent (AI-700) [Abstract]. AAPS PharmSci5, (2003).
   Google Scholar
• Walovitch RC, Kwan OL, Picard MH et al. Initial safety and myocardial perfusion imaging results with AI-700: a synthetic polymeric ultrasound contrast agent [Abstract]. J. Am. Soc. Echocardiogr.13, 457 (2000).
   Google Scholar
• Weissman N, Grayburn P, Klein A. Comparison of myocardial contrast ECHO to 99mTC MIBI SPECT in patients with myocardial perfusion defects: a Phase 2 study of AI-700 [Abstract]. J. Am. Soc. Echocardiogr.14, 461 (2001).
   Google Scholar
• Grayburn PA, Zoghbi WA, Weissman NJ et al. Comparison of AI-700 echo and nuclear perfusion imaging to coronary angiography in patients with suspected coronary disease [Abstract]. J. Am. Soc. Echocardiogr.17, 502 (2004).
   Google Scholar
• van der Wouw PA, Brauns AC, Bailey SE, Powers JE, Wilde AA. Premature ventricular contractions during triggered imaging with ultrasound contrast. J. Am. Soc. Echocardiogr.13(4), 288–294 (2000).
   PubMed Web of Science ®Google Scholar
• Yasumura S, Kubota I, Ikeda K, Tsuiki K, Yasui S. Using body surface mapping to detect vulnerability to ventricular arrhythmias in patients with coronary artery disease. J. Electrocardiol.20(2), 114–120 (1987).
   PubMedGoogle Scholar